Stay updated on BI 836858 & Decitabine Combo in AML Clinical Trial
Sign up to get notified when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.

Latest updates to the BI 836858 & Decitabine Combo in AML Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor version update with no visible changes to core content or functionality.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag v3.4.2 was added and the older funding/operating-status notice (v3.4.1) was removed; there are no changes to the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedAdded a site-wide funding/status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0 label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedAdded a glossary toggle and updated QC-related labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Standardized capitalization for 'No FEAR Act Data' (replacing 'No FEAR Act data').SummaryDifference0.2%

- Check64 days agoChange DetectedRevision history updated: Revision v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check85 days agoChange DetectedLocations section structure updated: added a general Locations section and state entries for Florida, Illinois, New York, and Ohio; removed Florida Locations, Illinois Locations, New York Locations, and Ohio Locations. Revision updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

Stay in the know with updates to BI 836858 & Decitabine Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.